Do you have Asthama?
If your symptoms are not fully controlled on your current treatment, the KALOS study may be an option.
What is the KALOS clinical study?
The KALOS study is for people with asthma whose symptoms are not fully controlled using their current inhaler treatment.
The study will see whether a new type of inhaler called BGF MDI may provide benefit to people with this type of asthma
The study will also be be used to help better understand asthma and other commonly linked conditions.
Who can join?
You may be able to join study if you:
What is involved in the study?
The study is split into 3 periods: screening, treatment, and follow-up. They will take place over a maximum of 58-weeks.
